Data from the surpass trial series revealed that tirzepatide reduces the risk of major adverse cardiovascular events and improves blood pressure, lipid profiles, and inflammatory markers (60, 61)
The ability to fine-tune dosing may help users find the minimum effective dose that produces the fewest GI side effects, thereby reducing dehydration risk
Outcome analysis: risk of depression Pooled effect estimate Across the 19 included studies, all authors reported an effect estimate for incident or worsening depression-related adverse events associated with GLP-1 receptor agonist (GLP-1 RA) exposure
[1] [3] This sterile injectable solution may be intended for use in patients requiring enhanced antioxidant support, detoxification, or adjunctive therapy in specific medical conditions
When Thornton enacted a Stage 1 drought declaration last week, it became the first city in metro Denver to place a mandatory twice-weekly limit on outdoor watering for the upcoming hot season